Suppr超能文献

艾司奥美拉唑剂量拆分对胃酸度及夜间酸突破的影响。

Effect of splitting the dose of esomeprazole on gastric acidity and nocturnal acid breakthrough.

作者信息

Hammer J, Schmidt B

机构信息

Abteilung für Gastroenterologie und Hepatologie, Universitätsklinik für Innere Medizin IV, Währinger Gürtel 18-20, A-1090 Vienna, Austria.

出版信息

Aliment Pharmacol Ther. 2004 May 15;19(10):1105-10. doi: 10.1111/j.1365-2036.2004.01949.x.

Abstract

BACKGROUND

Twice-daily dosing is increasingly used to improve gastric acid control, although not all proton-pump inhibitors are more effective when doses are split. Standard dose esomeprazole provides better gastric acid control than other standard dose proton-pump inhibitors.

AIMS

To compare the effect of standard dose esomeprazole (1 x 40 mg) with 20 mg b.d. on gastric acidity.

METHODS

Thirteen healthy subjects participated in this crossover study, receiving esomeprazole 2 x 20 mg and 1 x 40 mg for 7 days in random order with a washout period of at least 7 days. Gastric 24-h pH was measured on days 1, 2 and 6.

RESULTS

Median gastric 24-h pH was higher during 2 x 20 mg esomeprazole on day 2 (P < 0.01), no differences were detected on day 6. Night-time gastric acid suppression was significantly improved by 2 x 20 mg esomeprazole on all study days (P < 0.05). Nocturnal acid breakthrough was observed on all study days in subjects receiving 1 x 40 mg, but in only 85% (first night), 64% (second night), and 45% of subjects (sixth night) with 2 x 20 mg (P < 0.05).

CONCLUSION

Splitting the esomeprazole dose improves initial acid suppression, this effect starts at the first night. Maximal benefit is achieved on day 2, while the effect on night-time acid control is detectable during the entire first week of treatment.

摘要

背景

尽管并非所有质子泵抑制剂分剂量服用时效果更佳,但每日两次给药越来越多地用于改善胃酸控制。标准剂量的埃索美拉唑比其他标准剂量的质子泵抑制剂能更好地控制胃酸。

目的

比较标准剂量埃索美拉唑(1×40mg)与每日两次服用20mg对胃酸度的影响。

方法

13名健康受试者参与了这项交叉研究,随机接受2×20mg埃索美拉唑和1×40mg埃索美拉唑治疗7天,洗脱期至少7天。在第1、2和6天测量24小时胃pH值。

结果

在第2天,2×20mg埃索美拉唑治疗期间的24小时胃pH值中位数更高(P<0.01),第6天未检测到差异。在所有研究日,2×20mg埃索美拉唑显著改善了夜间胃酸抑制(P<0.05)。接受1×40mg治疗的受试者在所有研究日均观察到夜间酸突破,但接受2×20mg治疗的受试者仅在85%(第一晚)、64%(第二晚)和45%的受试者(第六晚)观察到夜间酸突破(P<0.05)。

结论

将埃索美拉唑剂量分开可改善初始酸抑制,这种效果在第一晚就开始出现。在第2天达到最大益处,而在治疗的第一周内对夜间酸控制的效果均可检测到。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验